Open AccessMP41-13 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: ANALYSIS OF CLINICAL AND GENOMIC SUBGROUPS FROM THE JAVELIN BLADDER 100 TRIAL
Author(s) -
Thomas Powles,
Daniel P. Petrylak,
Se Hoon Park,
Srikala S. Sridhar,
Claudia Caserta,
Antoine ThieryVuillemin,
Hyo Jin Lee,
Joaquim Bellmunt,
Yoshiaki Yamamoto,
Jeanny B. AragonChing,
Bo Huang,
Keith A. Ching,
Craig B. Davis,
Alessandra di Pietro,
Yohann Loriot,
Petros Grivas
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000002062.13
Subject(s) - javelin , avelumab , urothelial carcinoma , medicine , metastatic urothelial carcinoma , bladder cancer , immunotherapy , cancer , physics , pembrolizumab , throwing , classical mechanics